pISSN 1976-2283
eISSN 2005-1212

Cited by CrossRef (12)

  1. Sue Zhang, Jessica T. Ristau, Huy N. Trinh, Ruel T. Garcia, Huy A. Nguyen, Mindie H. Nguyen. Undertreatment of Asian Chronic Hepatitis B Patients on the Basis of Standard Guidelines: A Community-Based Study. Dig Dis Sci 2012;57:1373
    https://doi.org/10.1007/s10620-012-2137-0
  2. Scott Fung, Peter Kwan, Milotka Fabri, Andrzej Horban, Mijomir Pelemis, Hie-Won Hann, Selim Gurel, Florin A. Caruntu, John F. Flaherty, Benedetta Massetto, Phillip Dinh, Amoreena Corsa, G. Mani Subramanian, John G. McHutchison, Petr Husa, Edward Gane. Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B. Gastroenterology 2014;146:980
    https://doi.org/10.1053/j.gastro.2013.12.028
  3. Ha Na Park, Dong Hyun Sinn, Geum-Youn Gwak, Jee Eun Kim, Sang Youl Rhee, Sung June Eo, Yu Jin Kim, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo. Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease. Liver Int 2012;32:937
    https://doi.org/10.1111/j.1478-3231.2011.02749.x
  4. Moon Seok Choi, Dong Hyun Sinn, Su-A Kim, Yil Seob Lee, Won Choi, Seung Woon Paik. The Clinical and Laboratory Characteristics of Patients with Chronic Hepatitis B Using Current or Past Antiviral Therapy in Korea: A Multi-Center, Nation-Wide, Cross-Sectional Epidemiologic Study. Gut Liver 2012;6:241
    https://doi.org/10.5009/gnl.2012.6.2.241
  5. Javier Fuentes Olmo, Rafael Uribarrena Amézaga. Tratamiento actual de la hepatitis B: ¿dónde encajan los nuevos análogos de los núcleos(t)idos?. Gastroenterología y Hepatología 2011;34:492
    https://doi.org/10.1016/j.gastrohep.2011.02.009
  6. Nghia H. Nguyen, Vincent Nguyen, Huy N. Trinh, Brian Lin, Mindie H. Nguyen. Treatment Eligibility of Patients With Chronic Hepatitis B Initially Ineligible for Therapy. Clinical Gastroenterology and Hepatology 2013;11:565
    https://doi.org/10.1016/j.cgh.2012.12.028
  7. Dan-Hong Yang. Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients. WJG 2015;21:2746
    https://doi.org/10.3748/wjg.v21.i9.2746
  8. Kyung Hee Kim, Dong Hyun Sinn, Won Kyoung Yun, Hyun Chin Cho, Yun Young Lee, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Byung Chul Yoo, Seung Woon Paik. Defining Virologic Relapse in Chronic Hepatitis B. Dig Dis Sci 2011;56:2432
    https://doi.org/10.1007/s10620-011-1597-y
  9. Kathryn M. Kitrinos, Amoreena Corsa, Yang Liu, John Flaherty, Andrea Snow-Lampart, Patrick Marcellin, Katyna Borroto-Esoda, Michael D. Miller. No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B. Hepatology 2014;59:434
    https://doi.org/10.1002/hep.26686
  10. Kounpiélimé Sosthène Somda, Abdel Karim Sermé, Aboubacar Coulibaly, Steve Léonce Zoungrana, Inès Compaoré, Serges Kouamou, Damien Ouattara, Roger Sombié, Alain Bougouma. Treatment of HBeAg-Negative Chronic Hepatitis B Patients with Nucleos(t)ide Analogues in Burkina Faso. OJGas 2016;06:387
    https://doi.org/10.4236/ojgas.2016.612041
  11. Chau-Ting Yeh, Tiffany Chen, Chao-Wei Hsu, Yi-Cheng Chen, Ming-Wei Lai, Kung-Hao Liang, Tse-Ching Chen. Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B. BMC Cancer 2011;11
    https://doi.org/10.1186/1471-2407-11-398
  12. Nghia H Nguyen, Huy N Trinh, Thuan T Nguyen, Son T Do, Phuong Tran, Huy A Nguyen, Khanh K Nguyen, Ruel T Garcia, Glen A Lutchman, Mindie H Nguyen. Safety and efficacy of entecavir in adefovir-experienced patients. J Gastroenterol Hepatol 2015;30:43
    https://doi.org/10.1111/jgh.12728